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Abstract1
Inflammation, airway hyper-responsiveness and airway remodelling are well-established hallmarks of asthma, but their
inter-relationships remain elusive. In order to obtain a better understanding of their inter-dependence, we develop a
mechanochemical morphoelastic model of the airway wall accounting for local volume changes in airway smooth muscle
(ASM) and extracellular matrix in response to transient inflammatory or contractile agonist challenges. We use constrained
mixture theory, together with a multiplicative decomposition of growth from the elastic deformation, to model the airway wall
as a nonlinear fibre-reinforced elastic cylinder. Local contractile agonist drives ASM cell contraction, generating mechanical
stresses in the tissue that drive further release of mitogenic mediators and contractile agonists via underlying mechanotransduc-
tive signalling pathways. Our model predictions are consistent with previously described inflammation-induced remodelling
within an axisymmetric airway geometry. Additionally, our simulations reveal novel mechanotransductive feedback by which
hyper-responsive airways exhibit increased remodelling, for example, via stress-induced release of pro-mitogenic and pro-
contractile cytokines. Simulation results also reveal emergence of a persistent contractile tone observed in asthmatics, via
either a pathological mechanotransductive feedback loop, a failure to clear agonists from the tissue, or a combination of both.
Furthermore, we identify various parameter combinations that may contribute to the existence of different asthma phenotypes,
and we illustrate a combination of factors which may predispose severe asthmatics to fatal bronchospasms.
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1 Introduction18
Asthma is a chronic lung disease characterized by inflamma-19
tion, airway hyper-responsiveness (excessive bronchocon-20
striction in response to relatively low doses of contractile21
agonist; AHR) and airway remodelling. The last of these22
involves a series of structural changes, including thickening23
of the epithelial layer and subepithelial basement membrane24
(SBM; the collagen-dominated inner layer of the airway)25
and of airway smooth muscle (ASM) bundles (Holgate 2011;26
Brightling et al. 2012; James et al. 2012; Berair et al. 2013).27
While each of these three features contributes to asthma28
severity, how they interact is poorly understood. Most impor-29
tantly, it is not clear whether AHR or remodelling are causes30
or consequences of the disease.31
We hypothesize that while airway remodelling is initiated32
by inflammatory mediators, it is perpetuated by mechani-33
cal factors. The complexity of the underlying biochemical34
and mechanical processes, which span multiple length and35
timescales, makes identification of key interactions solely36
from biological experiments on isolated processes partic-37
ularly challenging. Our aim is, therefore, to investigate38
the combined effect of repeated, short timescale, inflam-39
matory episodes and associated mechanical forces, arising40
from ASM cell (ASMC) contraction, on long-term airway41
remodelling. To this end, we present a novel, quantita-42
tive mechanochemical modelling framework (informed by43
appropriate in vitro and in vivo studies) that integrates these44
processes for the first time. We use this model to elucidate45
emergent system dynamics and thereby identify key under-46
lying pathogenic processes.47
Although inflammation is considered to be the main pro-48
cess by which airway remodelling occurs, based on in vitro49
(Brightling et al. 2012; Dekkers et al. 2012; Noble et al. 201450
and references therein) and animal (Sjöberg et al. 2017; Alri-51
fai et al. 2014; Silva et al. 2008; Zhu et al. 1999) studies, the52
causative effects of inflammation on remodelling are not fully53
supported by clinical trial or epidemiological data. For exam-54
ple, controlling inflammation with inhaled corticosteroids55
does not change the extent of airway remodelling or the56
decline of lung function with age (Guilbert et al. 2006; Strunk57
2007). Moreover, airway remodelling may occur in early life58
in the absence of inflammation (James et al. 2012, 2009).59
Bronchoconstriction, in the absence of inflammation, can60
also promote airway remodelling (Kistemaker et al. 2014;61
Oenema et al. 2013; Ge et al. 2012; Grainge et al. 2011; Tatler62
et al. 2011). In addition to the structural changes present in63
asthmatic airways, there is increasing evidence of altered64
baseline contractile tone that is thought to be the result of65
the chronic presence of contractile agonist or inflammatory66
mediators (Brightling et al. 2002).67
It is not clear how this persistent tone arises, but it could68
enhance AHR (Bossé et al. 2009). Additionally, intra-subject69
heterogeneity of tone in asthmatics has been proposed as 70
a cause of AHR (Brown and Togias 2016). Given that the 71
area fraction of ASM in human biopsies has been shown to 72
increase with the degree of asthma severity (Hassan et al. 73
2010), altered tone and ASM mass are likely interrelated. 74
Furthermore, airway remodelling is also associated with 75
extracellular matrix (ECM) changes (Kuo et al. 2011) and 76
SBM thickening (Benayoun et al. 2003). 77
Inflammation in the airways is the protective response 78
to allergen challenges, and is characterized by the recruit- 79
ment of inflammatory cells (such as eosinophils), activation 80
of resident mast cells, and over-expression of cytokines 81
and chemokines (Brightling et al. 2003). Some of the lat- 82
ter interact directly with ASM to trigger contraction, and/or 83
interact with mast cells causing them to degranulate, pro- 84
ducing histamine and other contractile agonists (Kostenis 85
and Ulven 2006). Inflammatory cells release mediators that 86
also have the ability to induce remodelling (e.g. TGF- 87
β; Halwani et al. 2011). Subsequently, the inflammatory 88
cells and cytokines are gradually cleared from the tissue. 89
Allergen challenges in humans are typically random, but 90
in mouse models of asthma, inflammatory and contractile 91
agonist challenges are administered and controlled artifi- 92
cially. 93
Tissue mechanics plays a significant role in airway remod- 94
elling and bronchoconstriction. For example, mechanical 95
strain increases ASMC proliferation (Smith et al. 1994) and 96
contractile protein expression (Smith et al. 1997, 1995). In 97
addition, TGF-β is a cytokine that mediates remodelling by 98
inducing both cell proliferation and ECM protein produc- 99
tion (Halwani et al. 2011), as well as having a potential 100
contractile agonist role (Desmoulière et al. 2005; Grinnell 101
and Ho 2002; Montesano and Orci 1988). It is activated 102
by ASMCs (Tatler et al. 2011), likely during bronchocon- 103
striction (Oenema et al. 2013; Tatler and Jenkins 2012) via 104
mechanical stretch from latent complexes that are tethered to 105
the ECM and to the ASMC (Froese et al. 2016; Noble et al. 106
2014; Wipff et al. 2007). Moreover, bronchial epithelial cells 107
under mechanical compression shed growth factors such as 108
endothelin-1 (ET-1), early growth response-1 (EGR-1) and 109
TGF-β (Tschumperlin and Drazen 2006, 2001; Tschumper- 110
lin et al. 2004) as well as to signal lung fibroblasts to express 111
ECM proteins in vitro (Swartz et al. 2001). 112
The heterogeneous micro-mechanical stress environment, 113
generated by ASM contraction, can be quantitatively and 114
qualitatively very different in normal versus remodelled air- 115
ways (Hiorns et al. 2016). Associated mechanotransductive 116
processes may influence ECM deposition and ASM pro- 117
liferation and migration. While it is recognized that these 118
mechanisms play a crucial role in numerous developmental, 119
physiological and pathological processes in other diseases 120
(Hoffman et al. 2011; Martinez-Lemus et al. 2009), we have 121
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yet to understand how these mechanisms contribute to AHR122
and airway remodelling in asthma.123
A significant body of work focusses on models of bron-124
choconstriction (e.g. Hiorns et al. 2014; Eskandari et al.125
2013; Politi et al. 2010; Wang et al. 2008; Latourelle et al.126
2002; Lambert and Paré 1997; Macklem 1996; Lambert127
et al. 1993), with much less attention paid to modelling128
of inflammation in the airways. Of particular relevance to129
this work are two of our previous models: firstly, our finite-130
thickness continuum-based model (Hiorns et al. 2014) of131
agonist-initiated contraction of the airway (represented as a132
nonlinear fibre-reinforced elastic material), which accounts133
for contractile force generation at the cell-level; secondly,134
our spatially-averaged (ordinary differential equation; ODE)135
model (Chernyavsky et al. 2014) of inflammation-driven136
switching of ASMCs from a contractile to a proliferative137
phenotype. The former predicts airway calibre changes and138
spatial stress heterogeneities, as a result of ASM contrac-139
tion and in response to pressure fluctuations that mimic tidal140
breathing. In the latter, resolution of inflammation is impli-141
cated as the key factor in driving ASM mass accumulation;142
however, this model does not account for mechanotrans-143
ductive feedback from mechanical stresses arising in the144
constricted remodelled airway wall. Thus, we combine and145
extend these two models by: (i) recasting our biomechanical146
model of the contractile airway into a well-established mor-147
phoelastic framework, that has been widely applied to growth148
and remodelling of soft tissues; and (ii) coupling this to the149
evolution of individual tissue constituents, using a multiphase150
description, governed by underlying biochemical processes151
such as inflammation-induced ASM phenotype switching,152
ASM cell proliferation or recruitment and ECM deposition,153
all of which can depend on mechanical stresses. Importantly,154
this coupled model accounts for two-way feedback between155
inflammation-driven changes in volume fractions of individ-156
ual airway constituents and their resulting mechanochemical157
environment.158
2 Methods159
2.1 Mathematical formulation160
We model the airway wall as a two-layered cylinder, repre-161
senting the inner collagenous SBM and an outer (predom-162
inantly) smooth muscle layer, within which accumulation163
of ASM mass and ECM deposition is driven by both bio-164
chemical and mechanical stimuli (Figs. 1, 2), neglecting (for165
simplicity) the sub-mucosal epithelial layer. We first outline166
a description of the elastic deformation (Fig. 1), consist-167
ing of the balance of linear momentum together with the168
constitutive specification of a hyperelastic mechanical law169
(Sect. 2.1.1). We then define the model inputs representing170
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Fig. 1 Configurations during finite growth of the airway wall. Top row:
Schematic of the evolution of the airway wall geometry with time, with
the colours correspoding to tissue constituent volume fraction. Middle
rows: Schematics of the airway geometry in the grown and stressed
configurations, at the indicated time. At initial time t0, the airway wall
is defined by inner radius R1, interface radius Rint , and outer radius
R2 in κ0, the original, stress-free reference configuration. Airway wall
growth is described by the mapping, G, from the original configura-
tion to κg , the grown, zero-stress configuration, defined by grown radii
ξ1, ξint (not shown), and ξ2 at time t1. The airway is deformed via F
to configuration κ , the current, stressed configuration, defined by radii
r1, rint , and r2, subject to pressure boundary conditions P1 and P2.
Bottom row: Schematics of transmural mechanical stress distributions,
generated from the active contraction and/or the elastic deformation,
and contractile agonist. The mechanical stress, τ , modulates certain
rates in the constitutive mass balance equations, e.g. (2.18, 2.21), to
influence growth, G
biochemical stimulation (Sect. 2.1.2). Finally (Sect. 2.1.3), 171
we construct the mass balance equations, incorporating 172
suitable biochemical and mechanotransductive processes 173
(Fig. 2). 174
2.1.1 Geometry and kinematics 175
The airway tissue is modelled as a mixture (Ateshian 2007; 176
Humphrey and Rajagopal 2002; Bowen 1976; Truesdell and 177
Toupin 1960) consisting of four phases: ASMCs in either a 178
contractile (c) or a proliferative (p) phenotype; a collagen- 179
dominated ECM (e); and an extracellular fluid (w) that also 180
transports soluble nutrient (not modelled) for tissue main- 181
tenance. The outer layer is composed of multiple phases 182
(predominantly ASMCs), and the inner layer, representing 183
the SBM, is composed entirely of the ECM phase. Follow- 184
ing the traditional continuum mechanics approach (Holzapfel 185
2000; Truesdell and Noll 1965), we assume initially (at time 186
t0) that each constituent a in the airway is in a (common) 187
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spatial, unstressed and unstrained reference configuration188
denoted κ0, in which the position of a particle is given by X.189
We assume that the airway is an axisymmetric thick-walled190
cylinder of fixed length. We define fixed polar cylindri-191
cal co-ordinates R,Θ, Z in the radial, circumferential and192
axial directions, respectively, with the inner layer occupying193
R1 ! R ! Rint, and the outer layer Rint ! R ! R2 (Fig. 1).194
In Fig. 1, G is a topological mapping from κ0 to an interme-195
diate “grown” configuration κg , in which the position of a196
particle originally at X is given by ξ(X, t), with cylindrical197
co-ordinates:198
ξ = ξ (R, t) ,ϑ = Θ, ζ = Z , (2.1)199
where we have assumed the airway maintains axisymmetry200
and zero axial growth. The airway in the grown configura-201
tion κg is deformed to a stressed configuration κ , and the202
position of a particle originally at ξ is now at x(ξ), with203
the mapping given by the deformation gradient tensor F.204
The total deformation is given by using the standard mul-205
tiplicative decomposition, H = FG. For concision, explicit206
dependence on time is suppressed here and throughout.207
For simplicity, we impose a plane-strain approximation,208
axisymmetry, and zero axial displacement. Thus, the defor-209
mation from κg to κ is given by210
r = r(ξ), θ = ϑ, z = ζ, (2.2)211
so that the elastic deformation gradient tensor is given by212
F = diag
[
∂r
∂ξ ,
r
ξ , λz
]
. (2.3)213
Assuming incompressibility, det(F) = 1 thus gives214
r2 = r2int + ξ2 − ξ2int, (2.4)215
where rint = r(ξint). The initial airway geometry (Online216
Resource 2) is chosen to match the bovine airways used in217
LaPrad et al. (2010), from which the mechanical properties218
are obtained. These are similar in size and structure to gen-219
eration 4 human airways (Harvey et al. 2013; Coxson et al.220
2008; Williamson et al. 2011). The interface radius is chosen221
based on human airway histology (Benayoun et al. 2003).222
Mechanical properties We assume the tissue is a nonlinear223
hyperelastic heterogeneous (multiphase) anisotropic mate-224
rial (Bowen 1976; Truesdell and Noll 1965; Truesdell and225
Toupin 1960). The formulation for obtaining the constitu-226
tive mechanical relation for this type of material is given in227
detail by Ateshian and Ricken (2010) and Ateshian (2007).228
We neglect dissipative stresses and assume: that all solid229
constituents are constrained to move together (Humphrey230
and Rajagopal 2002); isothermality; electroneutrality; tissue231
Fig. 2 Overview of the biochemical mechanisms. Allergen or con-
tractile agonist challenges, f (t), specified to occur at times ti , drive
evolution of an inflammatory factor, µ, and contractile agonist con-
centration, k. The magnitude and rate of clearance of µ and k are
determined by constants aµ, ak , and cdµ, cdk , respectively. Inflamma-
tion leads to global release of contractile agonist at rate akµ. Contractile
agonist induces local ASMC contraction, and the resulting increased
mechanical stress τ releases further cytokines, with contractile ago-
nist properties, at rate ac. Contractile ASMCs undergo apoptosis (ca)
and switching to a proliferative phenotype (ccp). The proliferative
ASMCs divide (cp) and switch to a contractile phenotype at a (high)
constant rate (cpc). Both inflammation and mechanical stress drive
increases (from a baseline) in the contractile to proliferative switch-
ing rate (ccp(µ, τ )), and increasing mechanical stress drives increases
in the proliferation or recruitment rate (cp(τ )). ECM proteins degrade
(cde) and are deposited (cbe(µ)) at baseline rates during normal tissue
maintenance, with the latter increasing with inflammation. Proliferating
ASMCs produce additional ECM proteins (with rate cpe). Blue dot-
ted arrows indicate how constituent volume fractions are required for
computation of the mechanical stress (τ ), as illustrated in Fig. 1. Rate
constants are given in Online Resource 2
incompressibility; that stress arises from the elastic deforma- 232
tion only (i.e. the growth mapping does not impart stress); 233
and that viscous stresses are negligible. 234
Following Hiorns et al. (2014), we apply the commonly 235
used additive de-coupling of the active and passive Cauchy 236
stress tensors: 237
T = −p1 + Tpassive + Tactive, (2.5) 238
where 1 is the identity tensor and p is a Lagrange multiplier 239
enforcing incompressibility, with the passive stress given by 240
123
Journal: 10237 MS: 1037 TYPESET DISK LE CP Disp.:2018/6/5 Pages: 20 Layout: Large
Re
vi
se
d P
ro
of
A theoretical model of inflammation- and mechanotransduction-driven asthmatic airway remodelling
Tpassive = 2F∂Ψ
∂C
FT, (2.6)241
in which we highlight that, since the mixture is constrained,242
Fa = F. In (2.6), Ψ is the strain energy function per unit243
volume of the mixture,244
Ψ = ∑
a=p,c,e
ΦaWa, (2.7)245
and Wa is the strain energy function per unit constituent vol-246
ume of constituent a (Ateshian 2007; Huyghe and Janssen247
1997), noting that the fluid phase (w) does not contribute to248
the mechanical response of the tissue.249
The contractile ASMCs and collagen-dominant ECM250
form continuous fibre-like structures (Ijpma et al. 2017) and251
therefore are modelled as two sets of helical fibres wrapped252
symmetrically about the airway axis (to avoid torsion). The253
active stress in (2.5) is given by254
Tactive = Φc Acm( j)c ⊗m( j)c , (2.8)255
where Ac is the contractile force density, defined as the force256
generated by the contractile ASMCs per unit area of con-257
stituent (Brook et al. 2010) and m( j)c is the contractile ASMC258
fibre orientation vector (see Online Resource 1.1 for further259
details).260
Specification of the constitutive mechanical response for261
the airway wall constituents In our previous work (Hiorns262
et al. 2014), the airway wall is modelled as a composite mate-263
rial of ASMCs and ECM, in which two families of fibres264
are embedded in an isotropic ground matrix, thus giving265
an anisotropic response. Fibre recruitment is modelled phe-266
nomenologically with an exponential dependence on stretch.267
Here, we de-couple the mechanical responses of the pro-268
liferating ASMCs, modelled as an isotropic neo-Hookean269
material; the contractile ASMCs, modelled as the fibre-270
embedded material described above, and the ECM, modelled271
similarly under the additional assumption that collagen fibres272
bear load only after being extended beyond the recruitment273
stretch, λu (Hiorns et al. 2014; Hill et al. 2012; Robertson274
et al. 2011; Holzapfel and Ogden 2010). The strain energy275
functions for each of the constituents are given in Online276
Resource 1.2.277
We introduce a scalar quantity τ representing the mechan-278
ical stress along the contractile ASMC fibre directions, given279
by280
τ = 1
2
∑
j=1,2
T : m( j)c ⊗m( j)c , (2.9)281
which is used in the mass balance equations in Sect. 2.1.3282
to elicit the mechanotransductive responses. The degree of283
contraction is directly related to the amount of agonist bound284
to the relevant contractile ASMC receptors. We therefore 285
assume that the contractile force density, Ac in (2.8), is a 286
function of contractile agonist concentration, k, saturating as 287
follows: 288
Ac = Tc k
n
Kd + kn , (2.10) 289
where Tc is a measure of hyper-responsiveness, Kd repre- 290
sents the ratio of the dissociation rate of the ligand-receptor 291
complex to its association rate, and n is the Hill coefficient, 292
describing cooperativity. 293
Balance of linear momentum In addition to the assump- 294
tions stated above, we further assume that body forces 295
are negligible and inertial terms may be neglected due to 296
slow timescales associated with quasi-static deformation. 297
Therefore, in mechanical equilibrium, conservation of lin- 298
ear momentum requires 299
∇ · T = 0. (2.11) 300
Under the assumption of no torsion and plane strain, (2.11) 301
reduces to 302
∂Trr
∂r
+ Trr − Tθθ
r
= 0, (2.12) 303
where Trr is the radial component and Tθθ the circumferential 304
component of the Cauchy stress. 305
Boundary conditions for the elastic deformation For the 306
elastic deformation, pressure boundary conditions are spec- 307
ified at the inner and outer radii, and continuity of radial 308
displacements and stress at the interface, so that 309
Trr (r1) = −P1, (2.13a) 310
r (i)(ξint) = r (o)(ξint) ≡ rint. (2.13b) 311
T (i)rr (rint) = T (o)rr (rint), (2.13c) 312
Trr (r2) = −P2. (2.13d) 313
314
2.1.2 Model inputs 315
We assume that a series of transitory allergen challenges 316
drives a global inflammatory response that represent an influx 317
of inflammatory cells, such as eosinophils, into the airway tis- 318
sue, resulting in a cumulative inflammatory status denotedµ. 319
The challenges may be administered (e.g. in chronic asthma 320
mouse models), or occur naturally. Therefore, µ evolves 321
according to 322
dµ
dt
= aµ f (t)− cdµµ, (2.14) 323
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where cdµ is the inflammation decay rate representing324
clearance of inflammatory cytokines or inflammatory cell325
apoptosis, and aµ the magnitude, and f (t) denotes the tim-326
ing of events given by (2.16).327
Inflammation drives a local activation of mast cells and328
bronchoconstrictive mediators (represented by the concen-329
tration k) such as histamine or acetylcholine (Pelaia et al.330
2008). The agonist induces active contraction of the ASM,331
which leads to airway narrowing together with associated332
local airway wall stresses. We assume that the local ten-333
sile stress, τ (2.9), induces activation of latent TGF-β; this334
cytokine also acts as a contractile agonist and therefore335
contributes to k. We also consider cases where local com-336
pressive stress drives remodelling. These cases represent337
compression-induced epithelial-cell-mediated expression of338
EGR-1 or ET-1, noting that, here, we do not model the epithe-339
lial cells directly.340
As with inflammation, the frequency of contractile agonist341
challenges may be specified as model input to represent, for342
instance, artificial methacholine challenges in animals (Lau-343
zon and Bates 2000; Gunst et al. 1988) or humans (Grainge344
et al. 2011). Contractile agonist, k, thus evolves over time345
according to346
dk
dt
= ak f (t)− cdkk + akµµ+ acτH(τ ), (2.15)347
where cdk is the agonist clearance rate, ak the magnitude of348
administered agonist stimuli, akµ the rate of inflammation-349
induced agonist activation, and ac the rate at which the350
stress τ induces agonist release. The Heaviside step function351
H ensures that only tensile stresses release k (Wipff et al.352
2007).353
By setting aµ = 0 or ak = 0 in 2.14 and 2.15, f (t)354
represents either contractile agonist- or inflammatory-only355
challenges, respectively. The challenges are represented by356
a series of Gaussian peaks357
f (t) = 1√
2πσ 2
N∑
i=1
[
exp−d(t−ti )2/2σ 2
]
, (2.16)358
where ti is a vector of N event times, and d and σ are con-359
stants (Chernyavsky et al. 2014).360
2.1.3 Tissue growth361
Under the assumption of axisymmetry, in cylindrical polar362
co-ordinates, the local density, ρa, of each constituent (a =363
c, p, e, w) evolves according to:364
∂ρa
∂t
+ v ∂ρa
∂ξ
+ ρa 1
ξ
∂(ξv)
∂ξ
= sa (2.17)365
where ρa and the (constrained mixture) radial growth veloc- 366
ity, v, are functions of the grown radius, ξ (Fig. 1), and time, 367
t ; sa = sa
(
ρc, ρp, ρe
)
represents the constituent-dependent 368
source/sink terms, specified in detail below. 369
We assume that the density of contractile ASMCs, ρc, 370
evolves through switching to and from a proliferative pheno- 371
type,ρp (Fig. 2; Naveed et al. 2017; Wright et al. 2013; Hirota 372
et al. 2009). The definition of ASMC phenotype is based on 373
the observable function of the cells arising from expression 374
of intracellular proteins, e.g. proliferative ASMCs exhibiting 375
decreased expression of contractile proteins (Wright et al. 376
2013). As in our previous model (Chernyavsky et al. 2014), 377
the rate of switching is governed by the inflammatory status, 378
µ, but here we additionally assume that switching can also 379
be driven by the local fibre mechanical stress τ . Thus, 380
sc = cpcρp − caρ2c − ccp (µ, τ ) ρc, (2.18) 381
where cpc and ca are positive constants, the first two terms 382
representing switch back from the proliferative phenotype 383
and apoptosis, respectively, the combination of which pro- 384
vides a logistic growth representation. ccp represents the 385
inflammation- and stress-modulated rate of switching to the 386
proliferative phenotype given by 387
ccp(µ, τ ) = cc0 + (cc1 − cc0) H(µ− µ1)
+ (cc2 − cc1) H(µ− µ2)+ ccτ (τ )τ, (2.19) 388
where cc0, cc1, cc2 and ccτ are positive constants. The Heav- 389
iside functions are used to divide the inflammation into three 390
levels: healthy, mild, and severe, which are characterized by 391
the thresholds µ1 and µ2 (Fig. 3). The final term represents 392
local mechanical stress-induced switching: 393
Fig. 3 Inflammation levels. Inflammatory status dynamics induced
by a series of environmental stimuli, illustrating the parameters
µ1, µ2, aµ, cdµ, and ti , noting that for periodic events, ti+1 − ti = ∆t
and ω = 1/∆t . The solid line represents relatively fast inflammatory
clearance (high cdµ), while the dotted line represents slow clearance
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ccτ (τ ) =
⎧⎨⎩c
f
cp H(τ ) if tension induces switching,
c
f
cp H(−τ ) if compression induces switching.
394
(2.20)395
Increases in proliferative ASMC density, ρp, arise via396
proliferation and phenotype switching. Thus, proliferative397
ASMC turnover, sp, is represented by398
sp = (cp(τ )− cpc) ρp + ccp(µ, τ )ρc, (2.21)399
where the proliferation rate (cp(τ )) is modulated directly by400
the local stress τ according to401
cp(τ ) = cp0 + cpτ τ, (2.22)402
representing baseline and a (tensile or compressive) stress-403
driven proliferation, of identical form to (2.20) but with rate404
constant c fp .405
ECM turnover is modelled via406
se = cpeρp + cbe(µ)− cdeρe, (2.23)407
where the first term represents ECM synthesis by the prolif-408
erative ASMCs, e.g. via ASMC-mediated release of active409
TGF-β that induces ASMCs to synthesize collagen (Coutts410
et al. 2001); the second term represents modification of411
ECM by inflammatory mediators, e.g. via mast cell activation412
mediated by MMP-1; and the third term, linear degradation.413
The inflammation-driven ECM deposition is given by414
cbe(µ) = ce0 + (ce1 − ce0) H(µ− µ1)415
+ (ce2 − ce1) H(µ− µ2), (2.24)416
where, again, the Heaviside function is used to separate the417
three inflammation levels.418
For simplicity, each of the constituents is considered419
intrinsically incompressible, i.e. their true densities (ρTa )420
remain constant in space and time (Ateshian 2011), and we421
assume that the true densities of the ASMCs and ECM are422
equal, a reasonable assumption in general (Gleason et al.423
2004). In the following, we work in terms of the volume424
fraction, defined by Φa = ρa/ρTa , and correspondingly write425
the source/sink terms as Sa = sa/ρTa . Assuming no voids, we426
obtain427 ∑
a
Φa = 1. (2.25)428
Equation (2.17), together with the definition of volume429
fraction and the source/sink terms, is re-expressed as430
∂Φa
∂t
+ v ∂Φa
∂ξ
+Φa
(
1
ξ
∂
∂ξ
(ξv)
)
= Sa (2.26)431
where the volume fractions, Φa, are functions of the grown 432
radius, ξ (Fig. 1), and time, t , and a = c, p, e. As in Gleason 433
et al. (2004), we assume that a constant and uniform tissue 434
hydration is maintained, such that Φw = 0.70. Summation of 435
(2.26), together with (2.25), gives the mass balance equation 436
for the entire mixture as 437
1
ξ
∂
∂ξ
(ξv) = (Sc + Sp + Se) / (1−Φw) = q. (2.27) 438
We note that: Φe is obtained using (2.25); Sc, Sp and Se 439
are functions of Φc,Φp and Φe. Thus (2.25), (2.27) and 440
(2.26), together with initial conditions on Φa (see Online 441
Resource 2), ξ and boundary conditions on v, completely 442
specify the time-evolving growth mapping G, provided 443
that the mechanical stress state can be computed (Fig. 1; 444
Sect. 2.1.1). 445
Initial and boundary conditions on tissue growth During 446
normal tissue maintenance, in the absence of inflammation 447
or administered contractile agonist, we assume that ASM 448
proliferation, recruitment and apoptosis, and ECM degrada- 449
tion and deposition in the airway wall balance to generate a 450
homeostatic state. The non-trivial homogeneous steady state 451
for (2.26), for which v = 0, is given by 452
Φ∗p =
cpc
2
c0
ca(cpc − cp0)2ρTp
, (2.28a) 453
Φ∗c =
cp0cc0
ca(cpc − cp0)ρTc
, (2.28b) 454
Φ∗e =
ce0 + cpeΦ∗pρTp
cdeρTe
, (2.28c) 455
where we have made use of (2.18), (2.21), and (2.23). A linear 456
stability analysis of (2.26) ensures a priori that the steady 457
state (2.28) is stable. Hence, we impose this homeostatic 458
steady state as the initial condition 459
Φa(ξ, 0) = Φ∗a , a = c, p, e. (2.29) 460
A zero flux condition is imposed at the inner wall and 461
at the interface between the two layers, which in cylindrical 462
polar co-ordinates is given by 463
v(ξ1)
∂Φa
∂ξ
∣∣∣∣
ξ1
= 0, (2.30a) 464
v(ξint)
∂Φa
∂ξ
∣∣∣∣
ξint
= 0. (2.30b) 465
466
In order to solve the ODE (2.27) representing growth in 467
each layer, a boundary condition must be specified on the 468
velocity. However, because (2.27) is first order, one is unable 469
to specify the velocity at both the inner and outer boundaries 470
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of each layer. We therefore set the radial velocity to zero on471
the outer wall, so that all growth occurs inwardly (this choice472
is discussed further in Sect. 4). Additionally, we require the473
velocity and displacement at the interface of the two layers474
to be continuous. Hence, we have475
ξ(R2) = ξ2 = R2, (2.31a)476
ξ(R(i)int ) = ξ(R(o)int ) = ξint, (2.31b)477
v(ξ2) = 0, (2.31c)478
v(ξ
(i)
int ) = v(ξ (o)int ), (2.31d)479
where the superscripts (i) and (o) denote limiting values480
taken from the inner and outer layers, respectively.481
Inflammatory or agonist challenge protocol Episodes482
of inflammation-inducing allergen or contractile agonist483
challenges are represented by (2.16) in (2.14) or (2.15),484
respectively. Simulations are performed over a 1000 day485
interval, with the challenges confined to the first 50 days,486
thereby allowing a long resolution period to investigate the487
effects of the challenges on long-term airway remodelling488
post-challenge. The numerical solution method is outlined489
in Online Resource 1.3.490
2.2 Determination of material parameters491
The passive material parameters are determined by fit-492
ting (2.12) to the quasi-static pressure-radius inflation data493
in LaPrad et al. (2010) via nonlinear regression using494
lsqcurvefit.m in MATLAB, with termination tolerances495
set to default values. Material parameters are given in Online496
Resource 2, and the fit to the data (R2=0.9978) is depicted497
in the results below. The active response is determined498
by selecting values for Tc that qualitatively matched the499
active pressure-radius curves given in the work of Hiorns500
et al. (2014) for similar values of contractile agonist, k. All501
model parameter values and their descriptions are provided502
in Online Resource 2.503
3 Results504
To investigate the behaviour of our novel mechanochemical505
morphoelastic model, we first performed a one-at-a-time sen-506
sitivity study (Online Resource 3) on selected parameters of507
most relevance to airway remodelling. The analysis showed508
that remodelling was most sensitive to the magnitude and509
resolution rate of inflammation, during inflammatory chal-510
lenges. However, due to the possible effect of combination511
of the large number of parameters in this model (see Online512
Resource 2) and the large differences in remodelling that513
occur between inflammation and contractile agonist chal-514
lenges, we chose to perform a series of paired parameter515
explorations. These are used to investigate the effect of 516
repeated inflammatory episodes, and mechanical forces that 517
arise from repeated ASM contractions, on long-term airway 518
remodelling and effective mechanical properties of the air- 519
way. Parameters are set to default values unless varied in 520
the simulations. Results are discarded for parameter choices 521
that lead to airway growth or contraction completely into 522
the lumen, i.e. the inner radius decreases to zero. Unless 523
otherwise specified, remodelling occurs in the outer layer 524
only. 525
Effect of inflammatory challenges In our first set of sim- 526
ulations, we apply only inflammatory challenges (ak = 527
0), mimicking regular allergen exposures in experimental 528
studies, and explore the response to changes in challenge 529
frequency, ωµ, and inflammation resolution rate, cdµ. From 530
an initial inner radius of 1.8mm, we observe inward airway 531
remodelling towards the lumen, as depicted in Fig. 4a, show- 532
ing the inner radius at 5 days post-final challenge for each 533
parameter pair. In particular, we observe a “switch” effect, 534
in which the response is insensitive to increases in ωµ and 535
decreases in cdµ for a large region of parameter space, but 536
dramatic increases in remodelling occur beyond a thresh- 537
old parameter set. Contractile agonist retention time, defined 538
as the number of days between the final inflammatory or 539
agonist challenge and the reduction in the total amount of 540
agonist in the airway cross-section to near zero (< 1x10−6), 541
remains rather low for relatively high ωµ and low cdµ, and 542
is relatively insensitive to ωµ, but we observe a threshold 543
in cdµ below which the agonist resolution time increases 544
abruptly to 15 days from a baseline of approximately 10 545
days. 546
Detailed results for a specific parameter choice (high- 547
lighted by circles in Fig. 4a) are shown in Fig. 4b–e. Static 548
pressure-radius curves are computed for time points dur- 549
ing and following inflammatory challenges (Fig. 4b). For 550
these parameter choices, the contractile agonist concentra- 551
tion remains low, since the rate of inflammation-induced 552
agonist release is relatively low, and very little ASMC con- 553
traction occurs. During challenges, the pressure-radius curve 554
shifts downward as the airway thickens due to inflammation- 555
induced remodelling. Following challenges, the curves con- 556
tinue to shift slightly downwards, due to a small amount of 557
post-challenge remodelling, prior to a return to the steady 558
state. 559
The total amount of ASM and ECM increases during 560
inflammatory challenges as ASMCs switch from contrac- 561
tile to proliferative phenotype, and their volume fractions 562
relative to that of ECM increase over time (Fig. 4c, d). Rela- 563
tively low mechanical stresses arise during challenges for this 564
parameter set, as inflammation induces only a small amount 565
of contractile agonist release, and hence contraction is also 566
minimal. We observe compressive radial stresses in the air- 567
way mid-wall. In the circumferential direction, the stresses 568
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Fig. 4 Effect of inflammatory challenges on airway remodelling and
mechanics. Variation in a remodelled geometry with inflammation fre-
quency (ωµ) and resolution (cdµ) parameter values. Illustrative results
are evaluated at the circled point on the surface: b pressure–radius curve
(red lines correspond to points during challenge; blue lines indicate res-
olution period; blue dots indicate data of LaPrad et al. 2010); c volume
fraction of proliferative ASMCs (Φp) as a function of radius and time,
d Φp and e Tθθ as functions of radius at days 28, 30, and 32 (indicated
by dotted lines in c). Additional plots are provided in Online Resources
4 and 5
are found to be tensile towards the outer edge of the airway569
wall and compressive near the lumen (Fig. 4e). Mechanical570
stresses in the axial direction are compressive due to tissue571
incompressibility (Online Resource 5).572
Effect of inflammatory challenge-induced ECM changes573
in the subepithelial basement membrane Next, to model574
SBM thickening associated with asthma, we allow for 575
inflammation-induced ECM deposition and degradation in 576
the SBM, as well as in the outer layer, by setting ce0, ce1, ce2 577
and cde in the inner layer to the default values given (for 578
the outer layer). The addition of inflammation-induced ECM 579
deposition results in increased inward remodelling (Fig. 5a), 580
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Fig. 5 Effect of inflammatory challenge-induced subepithelial base-
ment membrane thickening on airway remodelling and mechanics.
Variation in a remodelled geometry with inflammation frequency (ωµ)
and resolution (cdµ) parameter values. Illustrative results are evaluated
at the circled point on the surface: b pressure–radius curve (red lines
correspond to points during challenge; blue lines indicate resolution
period; blue dots indicate data of LaPrad et al. 2010) and c circumfer-
ential stress (Tθθ ) as a function of radius and time. Results are similar
to Fig. 4, except here, inflammation also drives SBM thickening
which, in turn, decreases effective airway compliance, as581
shown by modified pressure–radius curves (Figs. 5b, c,582
f, 4b). Compressive circumferential stresses in the SBM583
are correspondingly reduced (Fig. 5c), due to increased584
cross-sectional area. In contrast, peak tensile circumferential585
stresses in the outer layers are greater with SBM thickening,586
presumably as a result of a thicker, stiffer inner layer and587
therefore an effectively stiffer airway.588
Effect of contractile agonist challenges Here, we apply589
only contractile agonist challenges (aµ = 0), mimicking reg-590
ular methacholine exposures in experimental animal studies.591
We highlight that, in these simulations, all remodelling is592
driven by mechanotransduction, i.e. by local, stress-mediated593
phenotype switching. We find that increasing the agonist594
challenge frequency (ωk) and decreasing the contractile ago-595
nist resolution rate (cdk) lead to increased remodelling at 5596
days post-challenge. As in the inflammatory-only challenges,597
severe remodelling is observed only beyond a threshold598
parameter set. Contractile agonist resolution time increases599
with decreasing agonist resolution rate, cdk , with a thresh-600
old below which there is a dramatic change in resolution601
time from a baseline of approximately 5 days to over 60 602
days (Fig. 6a). The dramatic increase in resolution time is a 603
result of the build-up of agonist concentration demonstrated 604
by nonzero agonist concentrations at the end of each chal- 605
lenge (Online Resource 5). Similar to the inflammation-only 606
challenges, the contractile agonist resolution time is rela- 607
tively insensitive to the challenge frequency, ωk . 608
Despite the reduced ECM volume fraction in the outer 609
part of the airway (see Online Resource 5), the overall effec- 610
tive stiffness of the remodelled airway is increased during 611
contractile agonist challenges, as indicated by the contin- 612
ued downshift in pressure–radius curves at high transmural 613
pressures (Fig. 6b). To inflate the airway, a relatively high 614
transmural pressure is required to overcome the increased 615
contractile forces in the strongly contracted state, with a 616
strong downward shift at all pressures, and the appearance of 617
a significantly more compliant portion that shifts towards the 618
right. When the pressure is great enough to cause stretches 619
that exceed the recruitment threshold (see Sect. 2.1.1 and 620
Online Resource 1.2), there is a very rapid increase in the 621
recruitment of ECM. Tissue growth (increased airway thick- 622
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Fig. 6 Effect of contractile agonist challenges on airway remodelling
and mechanics. Variation in a agonist resolution rate with contrac-
tile agonist frequency (ωk ) and resolution (cdk ) parameter values.
Illustrative results evaluated at the circled point on the surface: b
pressure–radius curve (red lines correspond to points during challenge;
blue lines indicate resolution period; blue dots indicate data of LaPrad
et al. 2010), c contractile agonist concentration (k) as a function of
radius and time, d Φp and (e) Tθθ as functions of radius at days 28, 30,
and 32 (indicated by dotted lines on c). Additional plots are provided
in Online Resources 4 and 5
ness) also contributes to the observed downward shift. The623
separation of the effects of contractile agonist and tissue624
growth becomes clear following challenges, where the com-625
pliant portion of the curve disappears (first curve following626
challenges, Fig. 6b), and the high pressure portion of the627
pressure-radius curves shifts downwards as remodelling con-628
tinues post-challenge.629
As contractile agonist challenges cause the airways to con- 630
tract (Fig. 6c), local ASMC phenotype switching (Fig. 6d) 631
and local release of contractile agonist increase with increas- 632
ing tensile circumferential stress in the outer part of the 633
airway wall (Fig. 6e) that arises from the agonist-induced 634
contraction. Small amounts of locally activated residual con- 635
tractile agonist continue to drive remodelling post-challenge, 636
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generating a feedback loop that slows agonist clearance637
(Fig. 6a), accounting for build-up in agonist concentration.638
Effect of changes in intrinsic ASM hyper-responsiveness639
To simulate the effects of increasing intrinsic responsive-640
ness of ASMCs to contractile agonist, we return to the641
inflammation-only challenges and investigate the effect of642
paired changes in responsiveness (Tc) and challenge fre-643
quency (ωµ). We find that remodelling increases with Tc644
and ωµ (Fig. 7a), but a threshold effect only exists for645
increasing Tc. Increasing Tc also leads to much slower ago-646
nist clearance. At low values of Tc, the agonist eventually647
clears (Fig. 7a, b), while at high values, a self-perpetuating648
feedback loop is established (Fig. 7a, c), due to the local649
mechanotransduction-driven agonist release, which is not650
resolved, and the airway eventually grows in to the lumen.651
Global versus local effects of inflammatory and contrac-652
tile agonist challenges In Figs. 4 and 6, we illustrate the effect653
of varying frequency and resolution rate of inflammation- and654
contractile agonist-only challenges, respectively. Here, we655
compare instead the effects of varying amplitude and resolu-656
tion rate in these globally applied challenges (first and second657
columns, Fig. 8). Additionally, we compare these effects to658
changes in rates of inflammation- (akµ) and stress-mediated659
(ac) local contractile agonist release (third column, Fig. 8).660
Increasing the amplitude (aµ) and decreasing the reso-661
lution rate (cdµ) of inflammatory-only challenges lead to662
increased remodelling (Fig. 8a), without a clear threshold663
effect. Additionally, the degree of remodelling becomes less664
dependent on the inflammation amplitude for sufficiently fast665
resolution. At the (relatively low) default value of ASMC666
responsiveness, Tc, employed here, the contractile agonist667
clears rapidly from the tissue upon cessation of inflamma-668
tory challenges, due to the small amounts of local agonist669
activated by mechanical stress (Fig. 8d). Low levels of ago-670
nist release during inflammatory challenges results in limited671
contraction and therefore very low mechanical stresses.672
In contrast, we observe a very sharp threshold for increas-673
ing contractile agonist magnitude (ak ) and decreasing agonist674
clearance rate (cdk) (Fig. 8b). Locally activated agonist675
remains in the tissue longer at lower clearance rates, and676
its effect is evident in the transmural variations in circumfer-677
ential stress (Fig. 8f) in the time period following cessation678
of challenges (> day 50). High contractile agonist concen-679
tration induced by the agonist challenge generates significant680
bronchoconstriction and therefore relatively higher mechan-681
ical stresses than with inflammatory challenges.682
Increasing the rate at which inflammation induces con-683
tractile agonist release (akµ) exacerbates remodelling, and684
increasing the rate of stress-induced agonist release (ac)685
increases the positive mechanotransductive feedback, lead-686
ing to additional remodelling (Fig. 8c). With both an687
increase in stress-mediated feedback and in inflammation-688
induced contractile agonist release, agonist resolution time689
Fig. 7 Effect of airway smooth muscle cell hyper-responsiveness on
airway remodelling, active tone, and mechanotransductive feedback.
Variation in a remodelled geometry with inflammation frequency (ωµ)
and hyper-responsiveness (Tc) parameter values. Transmural contractile
agonist concentration is plotted as a function of radius at days 28, 30,
and 32 for parameter value pairs indicated by the circled points on a: b
where contractile agonist eventually clears from the tissue and c where
contractile agonist remains in the tissue in an indefinite feedback loop,
causing increasing remodelling long after cessation of challenges
is increased, though it remains significantly faster than with 690
direct contractile agonist challenge. Increasing akµ and ac 691
thus leads to an effective combination of inflammatory 692
and contractile agonist challenges, as increased contrac- 693
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(a) (b) (c)
(d) (e) (f)
Fig. 8 Global versus local effects on airway remodelling and active
tone. Variation in remodelled geometry (1st row) with parameter pairs:
inflammation magnitude and resolution (cdµ, aµ; 1st column), con-
tractile agonist magnitude and resolution (cdk , ak ; 2nd column), and
inflammation-induced contractile agonist release and mechanotrans-
ductive agonist release (akµ, ac; 3rd column). Circumferential stress
(2nd row) is plotted as a function of radius and time for parameter value
pairs indicated by the circled points on the surfaces
tion is observed during inflammatory challenges, and overall694
remodelling is higher than with agonist challenge alone. The695
higher levels of contractile agonist release during inflamma-696
tory challenges result in greater mechanical stresses (Figs. 8f)697
from agonist-induced bronchoconstriction.698
Effect of phenotype switching and proliferation rate mod-699
ulation by tensile versus compressive mechanical stress In700
all of the above simulations, we have assumed that only ten-701
sile stresses can increase phenotype switching (via (2.19) and702
nonzero c
f
cp in (2.20)) and that the proliferation rate of the pro-703
liferative ASMCs is unaffected by local stress (default value704
c
f
p = 0). Here, we investigate the effect of varying these705
parameters (in inflammatory-only challenges) for both ten-706
sile and compressive stress-modulated phenotype switching707
and proliferation/recruitment rate. We vary either the stress-708
induced switching rate (c fcp) or the proliferation rate (c fp ) and709
the contractile agonist clearance rate (cdk). Transmural dis-710
tributions of proliferating ASMC volume fraction at day 51711
(Fig. 9), selected from the overall results of this parameter712
exploration (Online Resource 6), illustrate the effects of these713
parameters on remodelling.714
We observe similar amounts of remodelling for increases715
in both tensile and compressive stress-modulated pheno-716
type switching rate and decreasing agonist clearance rate 717
with no clear threshold effect (see Online Resource 6). For 718
the same parameter ranges, agonist resolution times are 719
observed to be similar and relatively independent of c fcp for 720
both cases. Distributions of the proliferative ASMC volume 721
fraction significantly differ in the two cases, with larger vol- 722
ume fractions at the outer edge of the airway wall in the 723
tensile stress-modulated case and at the inner edge in the 724
compressive stress-modulated case (Fig. 9a), reflecting the 725
observed circumferential stress heterogeneity and contrac- 726
tile agonist build-up. For our given initial conditions (Online 727
Resource 2), both tensile and compressive stress-induced 728
increase in phenotype switching results in a greater amount 729
of airway remodelling than stress-induced increase in pro- 730
liferation rate (Fig. 9a, cf. b). Agonist retention is similar 731
between the two cases. 732
4 Discussion 733
The mechanisms underlying the interaction of inflamma- 734
tion, airway hyper-responsiveness and airway remodelling 735
in asthma are poorly understood. Thus, we have devel- 736
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Fig. 9 Effect of mechanotransductive mechanisms on airway mechan-
ics and remodelling. Volume fraction of proliferating airway smooth
muscle cells as a function of radius at day 51, for either tensile (solid
lines) or compressive (dotted lines) mechanical stress-induced changes
in ASMC (a) phenotype switching rate or b proliferation rate. Param-
eters for a are cdk = 0.83 and c fcp = 0.05 and for b are cdk = 0.50
and c fp = 0.05. Increased remodelling occurs in the former, even at a
higher agonist clearance rate
oped a new computational model of coupled biochemical-737
and mechanotransduction-induced remodelling of the air-738
way wall. In the model, accumulation of ASM and ECM is739
driven by switching of ASMCs from a contractile to prolifer-740
ative phenotype (which is capable of synthesizing ECM), and741
also, via a novel mechanotransductive feedback mechanism742
by which a mechanically stressed tissue releases mitogenic743
growth factors and contractile agonists.744
Our results qualitatively match those reported for asth-745
matic airways (as well as results from our previous model;746
see Online Resource 7). For example, we have predicted747
narrowing of the lumen and a downward shift in the pressure–748
radius curves that have been previously reported in humans749
(Williamson et al. 2011). Our model also predicts wall thick-750
ening of airways due to increased ASM volume, which has751
been reported both in asthmatic patients (James et al. 2012,752
2009) and in animal models (Alrifai et al. 2014).753
The inflammatory twitch hypothesis suggests that self-754
limiting inflammatory events are invoked in the presence of755
an allergic stimulus and dissipate as the stimulus disappears,756
with long resolution periods being a possible explanation for 757
the chronic inflammation characteristic of asthma (Pothen 758
et al. 2016). Our results suggest that these long resolution 759
periods may increase remodelling associated with severe 760
asthma. In animal models of asthma, for example, transitory 761
inflammatory cell recruitment, and increases in thickness of 762
both ASM bundles and the SBM, have been associated with 763
repeated/successive allergen challenges (Johnson et al. 2004; 764
McMillan and Lloyd 2004). This response is thought to be 765
the effect of pro-remodelling growth factors affecting acti- 766
vation of mast cells, ASM proliferation and ECM deposition 767
(Naveed et al. 2017; James 2017) or increased recruitment 768
of ASM progenitors such as myofibroblasts into the ASM 769
bundles (Gerarduzzi and Battista 2017; Singh et al. 2014; 770
Saunders et al. 2009). Thicknesses of both ASM bundles and 771
the SBM have been shown to gradually return to control lev- 772
els upon cessation of challenges (Alrifai et al. 2014; Leclere 773
et al. 2012), with the resolution periods of inflammation and 774
tissue growth being on the order of days to months (Pothen 775
et al. 2016; Alrifai et al. 2014), which is reflected in our sim- 776
ulations, in which inflammatory status, µ, remains elevated 777
with decreased clearance rate, cdµ. 778
Our work broadly follows that of Skalak (1980) and 779
Rodriguez et al. (1994) in which growth and remodelling 780
is treated as a topological mapping from a reference con- 781
figuration to a grown configuration followed by an elastic 782
deformation. A key component of this model is the implicit 783
separation of timescales between the growth and the (instan- 784
taneous) elastic deformations. This approach has previously 785
been applied to model airway narrowing (in which the folding 786
that occurs during growth was modelled utilizing buck- 787
ling theory; Moulton and Goriely 2011a, b), but this was in 788
the context of a single phase, and growth kinematics were 789
prescribed directly. Multiphase or mixture theory has been 790
utilized in numerous cardiovascular studies (e.g. Valentin 791
et al. 2013; Gleason and Humphrey 2005; Gleason et al. 2004; 792
Humphrey and Rajagopal 2003, 2002), where the models 793
were driven by evolution of the growth configuration of each 794
phase, but without consideration of their interactions. To our 795
knowledge, the approach taken here, in which the spatio- 796
temporal evolution of the individual tissue constituents is 797
driven by underlying biological and mechanochemical pro- 798
cesses, has not been considered in airway remodelling. Thus, 799
the multiphase model proposed here addresses the limitations 800
of previous models by considering in detail the interactions 801
between tissue constituents, as in the studies of Ateshian 802
(2007) and Aparício et al. (2016). We use our model to carry 803
out a series of parameter exploration studies to identify poten- 804
tial mechanisms underlying the pathogenesis and evolution 805
of asthma, described below. 806
Impaired resolution of inflammation may explain airway 807
remodelling characteristic of asthma As in our previous 808
model (Chernyavsky et al. 2014), slower resolution of inflam- 809
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mation has a greater effect on airway wall thickening than810
either challenge frequency or amplitude (Figs. 4a, 8a), as811
a result of slower clearance of residual pro-remodelling812
and pro-contractile cytokines (See Online Resource 7). This813
effect may be responsible for increased remodelling and814
bronchoconstriction observed in patients with severe asthma815
that is poorly controlled with anti-inflammatory medications,816
e.g. corticosteroids. In these cases, inflammation may not be817
effectively cleared, e.g. by failure to induce inflammatory818
cell apoptosis (Wenzel 2012; Woolley et al. 1996).819
Inflammation-independent bronchoconstriction-mediated820
mechanical stresses could drive airway remodelling Grainge821
et al. (2011) have demonstrated the possibility of inflam-822
mation-independent airway remodelling in asthmatics823
through application of methacholine-only challenges. Our824
model suggests the mechanisms by which this may occur. We825
show how tensile stresses along (circumferentially-oriented)826
muscle fibres, arising from agonist-induced contraction of827
ASMCs, can cause a local release of additional agonist828
(Fig. 6c). This mechanotransductive pathway may represent829
stretch-induced activation of latent TGF-β, which has both830
mitogenic (Halwani et al. 2011) and contractile agonist (Oji-831
aku et al. 2017; Oenema et al. 2013; Desmoulière et al. 2005;832
Grinnell and Ho 2002; Montesano and Orci 1988) properties.833
This additional local increase in agonist concentration trig-834
gers a local tensile stress-induced cell phenotype switching,835
thus driving increases in ASM mass. We have also shown that836
compressive stress-induced increases in phenotype switching837
or proliferation rate (Fig. 9), possibly mediated by shed-838
ding of growth factors such as EGFR and ET-1, could also839
explain the inflammation-independent remodelling observed840
in Grainge et al. (2011). Contractile agonists alone are insuf-841
ficient to induce physiological changes in mice, as measured842
with plethysmography (Mailhot-Larouche et al. 2018). Our843
simulations suggest that very frequent challenges, impaired844
agonist clearance or increased rate of stress-driven ago-845
nist activation is required to cause significant remodelling846
(Fig. 8b). It is possible that an intrinsic inability to clear847
agonist, increased sensitivity of ASM/ECM to stress-driven848
TGF-β activation or EGFR/ET-1 shedding could place the849
asthmatic subject in a high-risk region of the parameter space.850
Interaction of inflammation with intrinsic ASM hyper-851
responsiveness could explain persistent contractile tone and852
severe remodelling Our simulations show that increased853
intrinsic hyper-responsiveness causes increased remodelling854
(Fig. 7a) and significantly increased contractile agonist855
resolution times. This response is a result of increased bron-856
choconstriction at a given agonist concentration, driving857
increases in tensile stresses and hence further (mechan-858
otransductive) activation of pro-mitogenic mediators and859
contractile agonists such as TGF-β. These results high-860
light that the retention of contractile agonist associated with861
increased hyper-responsiveness is a candidate mechanism862
accounting for the persistent tone observed in asthmatics 863
(Brightling et al. 2002). As expected, long resolution times 864
are associated with impaired clearance of contractile agonist, 865
cdk (Fig. 6a). Notably, delayed contractile agonist resolution 866
occurs when both the ASMCs are very hyper-responsive and 867
inflammation challenge frequency is high. The combination 868
of identified mechanisms could therefore be responsible for 869
persistent contractile tone and remodelling, post-challenge, 870
in hyper-responsive airways (Kariyawasam et al. 2007). 871
Increased airway remodelling could occur via local 872
mechanotransductive effects An increase in both inflammation- 873
and mechanical stress-induced contractile agonist release 874
(Fig. 8c) leads to a condition that is an effective combination 875
of inflammation-only (Fig. 8a) and agonist-only challenge 876
(Fig. 8b). Increased rates of inflammation-induced agonist 877
release (akµ) could represent degranulation of the larger num- 878
bers of mast cells present in the ASM bundles of asthmatics 879
(Naveed et al. 2017) and hence the production of contractile 880
agonist (e.g. histamine). These released factors ultimately 881
elicit a pro-mitogenic response where (tensile) mechanical 882
stresses arising from ASMC contraction drive tissue remod- 883
elling via stress-induced phenotype switching of ASMCs. 884
Separately, under the assumption of mechanically activated 885
mediators (e.g. TGF-β), increasing stress-activated release 886
(ac) increases agonist-induced bronchoconstriction, leading 887
to further agonist release and thus further contraction and 888
stress-induced remodelling in a perpetual feedback loop. The 889
feedback mechanism may explain how coupled inflamma- 890
tion and bronchoconstriction lead to increased remodelling 891
in severe asthma. 892
Airway wall thickening may be a normal, local mechano- 893
protective response but ultimately becomes detrimental 894
to global lung mechanics and function The increase in 895
cross-sectional area from thickening of the SBM counter- 896
intuitively may serve to reduce mechanical stresses, arising 897
during bronchoconstriction (Fig. 5c). This reduction in stress 898
could, in turn, reduce compressive stress-driven shedding of 899
growth factors mediated by epithelial cells. Our model does 900
not allow for buckling of the SBM, due to our imposition 901
of axisymmetry, but reduced compressive stresses as a result 902
of the thicker SBM could also reduce propensity to buckle 903
(Moulton and Goriely 2011a) and hence limit airway nar- 904
rowing during bronchoconstriction. 905
Our results also indicate that remodelling-induced changes 906
in functional mechanical properties of the airways may 907
depend on what drove the remodelling. For instance, we 908
show that the pressure–radius curves during inflammation- 909
only challenges have qualitatively different characteris- 910
tics to those associated with agonist-only challenges (cf. 911
Fig. 4b, 6b). 912
Interaction of different underlying mechanisms may con- 913
tribute to the existence of different asthma phenotypes A com- 914
bination of various characteristics defines asthma subgroups, 915
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or phenotypes (see Wenzel 2012 and references therein).916
Here, we have identified various parameter combinations that917
may contribute to the existence of different asthma pheno-918
types. For example, the presence of eosinophils in the lung919
tissue is associated with thickened SBM, high expression of920
TGB-β, increased frequency and severity of symptoms, and921
more near-fatal events (Wenzel 2012; Miranda et al. 2004).922
Persistent eosinophils, despite corticosteriod treatment (typ-923
ically associated with eosinophil apoptosis), is associated924
with adult-onset, less allergic severe (TH 2) asthma (Wen-925
zel 2012). The slower clearance of inflammation leading to926
increased remodelling (Figs. 4a, 8a) and reduced contrac-927
tile agonist clearance may underlie this type of asthma. Our928
results (Fig. 5) suggest that a thickened SBM may be associ-929
ated with the increased presence of eosinophils, in agreement930
with the SBM thickness observed in non-eosinophilic com-931
pared with eosinophilic asthma (Miranda et al. 2004).932
Our results show that for regular bronchoconstrictive933
events to induce long-term airway remodelling an extreme934
set of consequences (Figs. 6, 8b) is required, which may935
be the reason why, to our knowledge, contractile agonist-936
induced remodelling has not been observed in animal studies937
(e.g. Mailhot-Larouche et al. 2018). However, the study by938
Grainge et al. (2011) shows that contractile agonist chal-939
lenges do lead to increased ASM thickness in humans. That940
mice do not spontaneously develop asthma but that humans941
do, suggests that the subjects of the Grainge et al. (2011)942
study may lie in a different region of parameter space, i.e.943
beyond the relevant thresholds.944
Methacholine challenges have been shown to increase air-945
way responsiveness in humans over the short term (Gazzola946
et al. 2017), and increased smooth muscle responsiveness947
may be independent of inflammation in some asthma phe-948
notypes (e.g. non-TH 2 asthma; Wenzel 2012). Our model949
suggests a possible mechanism: with intrinsically hyper-950
responsive ASMCs, normal exposure to contractile agonists951
alone (in the absence of inflammation) may be sufficient to952
drive further agonist release (Fig. 6b), and increase ASMC953
responsiveness, thus leading an asthma symptom phenotypes954
not typically associated with inflammation, such as exercise-,955
obesity-induced asthma, or non-TH 2 asthma.956
Increased ASMC hyper-responsiveness (Fig. 7) and/or957
increased mechanotransduction (Fig. 8c) may exacerbate958
remodelling, even at normal levels of inflammation (pauci-959
granulocytic asthma; Carr et al. 2017). Thus, these mecha-960
nisms may underlie the degrees of severity associated with961
inflammation-induced (TH 2) asthma: mild to moderate asth-962
matics may be characterized by increased inflammation but963
normal ASMC responsiveness (Fig. 4), while severe asth-964
matics may have increased hyper-responsiveness that leads to965
pathological remodelling (Fig. 7). Alternatively, mechanisms966
that reverse influx of inflammatory cells, and hence, return967
inflammation to normal levels, may have become impaired968
(Pothen et al. 2016; Brightling et al. 2012). A remodelled air- 969
way exhibiting a combination of the characteristics described 970
above may be primed for severe or even fatal bronchospasms 971
in which airway contraction completely obstructs airflow. 972
Model limitations and future work Models of this nature 973
necessarily require some simplifying assumptions. In partic- 974
ular, we have assumed that the airway remains axisymmetric 975
(and free of shear) during both growth and elastic deforma- 976
tion. This simplified approach, in which only radial growth 977
is considered, permits more straightforward analysis of the 978
effects of varying concentrations of tissue constituents and 979
contractile agonists across the airway wall. Nevertheless, our 980
model is novel in accounting for local mechanotransductive 981
effects and these spatial distributions. However, we note that 982
some growth may occur circumferentially and, possibly, axi- 983
ally, in vivo. Circumferential growth/atrophy has been shown 984
to underlie the development of residual stresses in arteries 985
(Rodriguez et al. 1994); however, airways have been shown 986
to exhibit little or no residual stresses (McKay et al. 2002), 987
and so we omit this growth mode from the model for sim- 988
plicity. Axial growth is similarly neglected, based on a lack 989
of experimental data on axial growth of airways. The growth 990
models of Ren (2013) and Grytsan et al. (2017) do account 991
for both isotropic and varying degrees of anisotropic growth 992
but do not consider heterogeneous spatial distributions. A 993
more comprehensive approach would be to extend the mod- 994
els analysed herein to 3D. However, the numerical solution 995
of the resulting equations is beyond the scope of the current 996
study. Additionally, our imposition of axisymmetry prevents 997
us from considering buckling of the stiff SBM. Future work 998
could involve utilizing this model to predict regions of high 999
compressive stresses in which buckling could occur (Moul- 1000
ton and Goriely 2011a). 1001
To solve (2.27), we specify zero radial velocity at the outer 1002
wall, so that growth occurs inwardly. We note that this choice 1003
is somewhat arbitrary and that the growth velocity could be 1004
specified at any point along the wall thickness. We choose 1005
to specify zero growth on the outer boundary based on evi- 1006
dence that airways appear to narrow during asthma. Studies 1007
on human bronchial segments have shown that increased 1008
ASM in asthmatics contributes to exaggerated airway nar- 1009
rowing (Noble et al. 2013). 1010
We do not allow for the separate evolution of the individ- 1011
ual constituents’ reference configurations, as in Humphrey 1012
and Rajagopal (2002). If our assumptions were relaxed so 1013
that these could move independently, interphase drag may be 1014
used to more accurately account for stress-induced activation 1015
of latent TGF-β. Moreover, changes in reference configura- 1016
tions, in addition to non-axisymmetric growth, could allow 1017
for the development of residual stresses. Although healthy 1018
airways exhibit negligible or small residual stresses (McKay 1019
et al. 2002), to our knowledge these have not been mea- 1020
sured in remodelled airways. Relaxing this constraint would 1021
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present a challenge in the theoretical development and in the1022
numerical solution that is beyond the scope of the current1023
work.1024
We have assumed that collagen fibre recruitment initiates1025
at stretches above unity, with an exponential function rep-1026
resenting gradually increasing fibre uncrimping. Rigorous1027
experimental analysis of the airway structure–function rela-1028
tionship, through coupled mechanical testing and advanced1029
microscopic imaging (e.g. Hill et al. 2012; Clifford et al.1030
2011), would enable incorporation of fibre dispersion and1031
recruitment to refine our model (e.g. Gasser et al. 2006;1032
Sacks 2003; Lanir 1983, 1979). Also, we have not accounted1033
for diffusion of applied contractile agonists, or of activated1034
cytokines such as TGF-β. Finally, migration of myofibrob-1035
lasts (ASM progenitors) into the muscle bundle has been1036
hypothesized as a mechanism of increased ASM. Although1037
this migration (and differentiation into ASMCs) has not1038
been modelled here explicitly, the ASMC proliferation in1039
our model could instead represent this recruitment of ASM1040
progenitors, and the timescale associated with migration is1041
implicitly accounted for in the proliferation rate (reinter-1042
preted as a ‘recruitment’ rate of myofibroblasts which then1043
become ASM).1044
Notwithstanding these limitations, key advantages of our1045
model are the ability to generate measurable biological and1046
mechanical output that may be tested experimentally and the1047
ability to separate the long-term effects of growth from the1048
relatively shorter term mechanical effects of pressurization1049
and active contraction. A study, combining the modelling1050
approach described here with experimental measurements1051
of tissue constitution, geometry, and active mechanics, is1052
required to distinguish between the effects of geometric1053
remodelling and changes in tissue mechanics.1054
Therefore, this work forms the theoretical basis of a model1055
that is currently being tested against data from in vivo animal1056
experiments, utilizing an ovalbumin model of inflammation-1057
induced asthma in mice. We have shown how the volume1058
fraction of constituents may be evaluated at any time along1059
the remodelling process (e.g. Fig. 4). These will be compared1060
to measurements made on histological sections taken from1061
animal models of asthma, to infer underlying mechanisms as1062
discussed above, and also for further model development and1063
validation. Additionally, we have demonstrated the ability to1064
assess mechanical properties of the airway as they evolve,1065
via computed pressure-radius curves (e.g. Fig. 4b) which1066
are commonly measured experimentally, to show changes in1067
passive and active tissue mechanics and distinguish between1068
healthy and diseased airways.1069
In addition to airway remodelling, the approach out-1070
lined in this paper has broad applicability to other areas1071
of tissue mechanics. For example, the mechanotransduc-1072
tive feedback mechanisms described herein likely have1073
direct applications to models of aneurysm growth (Gryt-1074
san et al. 2017; Aparício et al. 2016). Moreover, the 1075
coupled biochemical–biomechanical elements are relevant 1076
to inflammation-associated adventitial collagen deposition 1077
observed in arteries under hypertension (Bersi et al. 2016). 1078
Furthermore, the technique we present for modelling a 1079
non-homogeneous spatial distribution of tissue constituents 1080
would be applicable to the myocardium, since local changes 1081
in tissue constitution occur during mechanical overload, 1082
e.g. in hypertension-induced myocyte hypertrophy and col- 1083
lagen deposition (Hill et al. 2014) and during remod- 1084
elling following myocardial infarction (Gajarsa and Kloner 1085
2011). 1086
Conclusions Our results suggest that mechanical stresses, 1087
arising from bronchoconstriction, initiated by multiple 1088
inflammatory or contractile agonist challenges, and driving 1089
agonist release, generate a mechanotransductive feedback 1090
loop. With this feedback loop, increased ASM hyper- 1091
responsiveness to contractile agonists and impaired clearance 1092
of inflammatory factors and contractile agonists leads to 1093
increased remodelling, increased bronchoconstriction, and 1094
maintenance of an increased baseline contractile tone due to 1095
the chronic presence of contractile agonists. The key factors 1096
that allow such a state to emerge are (i) increased intrin- 1097
sic hyper-responsiveness of ASMCs to contractile agonists, 1098
(ii) delayed contractile agonist clearance from the tissue, 1099
(iii) increased release of contractile agonist by inflamma- 1100
tory cells, and (iv) mechanotransductive feedback, in which 1101
active contraction generates increases in mechanical stress 1102
that subsequently initiate the release of additional contractile 1103
agonists and thus exacerbate remodelling. Targeting mechan- 1104
otransductive pathways (e.g. TGF-β) and rapid resolution of 1105
inflammation or contractile agonist may have potential for 1106
treating severe forms of asthma. 1107
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1 Additional Mathematical Details
This section provides additional details about the model development and numerical solution techniques.
1.1 Fiber Directions
Considering a cylindrical body composed of an anisotropic material reinforced by two sets of fibers dispersed in
the ◊ ≠ z plane, the undeformed fibre directions in polar cylindrical co-ordinates are given by
m(1)0,a = cos«ae◊ + sin«aez, (S1a)
m(2)0,a = ≠ cos«ae◊ + sin«aez, (S1b)
for a given constituent a, where e◊ and ez are unit vectors in the circumferential and axial directions, respectively.
The current fibre direction, denoted m(j)a , is obtained from the undeformed fibre directions via a push-forward
operation,
m(j)a =
F ·m(j)0,aÒ
–(j)a
, (S2a)
where
–(j)a =m
(j)
0,a ·Cm(j)0,a, j = 1, 2, (S2b)
is the square of the fibre stretch ratio (Holzapfel, 2000), andC = FTF is the right Cauchy-Green tensor. We further
posit that all fibres, including both ASM and collagen fibres in the ECM, are oriented along the circumference
(Ijpma et al, 2017), so «a = « = 0¶.
1.2 Specific Forms of the Strain Energy Functions
Below we define the forms of the strain energy functions for the tissue constituents a = p, c, e. The neo-Hookean
form of the strain energy function for the proliferating (p) airway smooth muscle cells (ASMCs) is given by
Wp =
1
2÷p (I1 ≠ 3) , (S3a)
where ÷p is a material parameter representing the passive sti ness of proliferating cells, and I1 = trC is a strain
invariant. The form for the contractile (c) ASMCs is given by
Wc =
1
2÷c (I1 ≠ 3) +
ÿ
j=1,2
Cc
2—c
1
exp—c(–(j)c ≠1)
2 ≠ 1
2
, (S3b)
where material parameters are ÷c, representing the passive (isotropic) sti ness of contractile cells, Cc, representing
their passive (anisotropic) sti ness, and —c, accounting for nonlinear sti ening with increasing deformation. The
form for the extracellular matrix (ECM or e) is modeled similarly, so
We =
1
2÷e (I1 ≠ 3) +
ÿ
j=1,2
H
1
–(j)e ≠ ⁄u2
2 Ce
2—e
1
exp—e(–(j)e ≠⁄u2)
2 ≠ 1
2
, (S3c)
with material parameters ÷e, representing the passive (isotropic) sti ness of the embedded ECM cells, Ce, repre-
senting fibre density, and —e, parametrizing the gradual recruitment of collagen fibres.
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1.3 Numerical Solution Procedure
This section provides specific forms of the model equations that were used in the numerical scheme, as well as
the numerical techniques that were used to solve the PDEs. First, we derive the equations governing the growth
in each layer of the airway wall. Next, we derive a nonlinear equation that represents the elastic deformation of a
two-layer multi-phase cylinder subject to pressure boundary conditions. Finally, we discuss the specific numerical
schemes we used to solve these equations and the governing PDEs in the main text.
Growth. The radial growth of the airway is determined as follows. Integrating (2.27) with respect to › gives the
velocity in the outer layer as
›v(›)(o) =
⁄ ›
›int
›Õq(o)d›Õ +K1, ›int Æ › Æ ›2. (S4a)
Similarly, the velocity in the inner layer is given by
›v(›)(i) =
⁄ ›
›1
›Õq(i)d›Õ +K2, ›1 Æ › Æ ›int. (S4b)
The constants K1 and K2 are determined by applying the zero velocity boundary condition (2.31c) and continuity
of velocity at ›int (2.31d), respectively. The interface velocity is then given by (S4a) evaluated at › = ›int to give
v(›int) =
d›int
dt
= ≠ 1
›int
⁄ R2
›int
›q(o)d›, (S4c)
which is solved numerically for ›int. It is then used with (S4b) to obtain an expression for the velocity at the inner
wall, given by
v(›1) =
d›1
dt
= 1
›1
C
›intv(›int)≠
⁄ ›int
›1
›q(i)d›
D
, (S4d)
which is again solved numerically for ›1.
Elastic deformation. Integrating (2.12) and applying (2.13a) gives the radial stress for the inner layer
T (i)rr =
⁄ r
r1
1
rÕ
1
T (i)◊◊ ≠ T (i)rr
2
drÕ ≠ P1, r1 Æ r Æ rint, (S5a)
and applying (2.13d) gives the radial stress for the outer layer
T (o)rr = T (i)rr (rint) +
⁄ r
rint
1
rÕ
1
T (o)◊◊ ≠ T (o)rr
2
drÕ ≠ P2, rint Æ r Æ r2. (S5b)
Applying continuity of stress (2.13c) thus gives
P1 ≠ P2 =
⁄ rint
r1
1
r
1
T (i)◊◊ ≠ T (i)rr
2
dr +
⁄ r2
rint
1
r
1
T (o)◊◊ ≠ T (o)rr
2
dr, (S5c)
wherein r1 and r2 can be expressed in terms of rint via (2.4), since ›1 and ›int are known from the solution of
(S4), and (i) denotes variables computed in the inner layer and (o) those in the outer layer. Together with the
radial and circumferential stress components of the Cauchy stress specified by (2.5) and (S3), (S5c) is therefore
an algebraic equation in the unknown rint. At each time step, a root finding algorithm (fzero.m), is used to solve
the equilibrium equation (S5c) for rint. All other variables can be evaluated once this is known.
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Table 1: Initial Conditions and Airway Geometry
Parameter Definition Inner Outer Units
layer layer
µ|t0 Inflammatory factor, µ 0 0 mg mm≠3
k|t0 Contractile agonist, k 0 0 mg mm≠3
Õc|t0 Contractile ASMC 0 0.20
volume fraction
Õp|t0 Proliferating ASMC 0 1.50x10≠3
volume fraction
Õe|t0 ECM volume 0.30 9.85x10≠2
fraction
R1 Inner radius 1.800 mm
Rint Interface radius 1.818 mm
R2 Outer radius 2.340 mm
Numerical techniques. Numerical solutions to the system of coupled PDEs, given by (2.26), with (2.18-2.25), were
obtained via the method of lines as follows. A finite di erence spatial discretisation, with upwinding applied to
convective terms, was employed. For simplicity, we fixed with the number of nodes at 10 in the (thin) inner
layer and 100 in the outer layer, noting that, as the airway grows, ∆r is not constant1. The resulting system,
along with (S4), was time-stepped in MATLAB using an ODE solver (ode45.m or ode15s.m; the latter is used
when inflammatory or agonist challenge frequency is very high resulting in a sti  system of equations), with the
integrals evaluated using trapz.m. This method was applied separately to the inner and outer layers and solutions
matched at rint.
2 Model Parameters and Initial Conditions
Initial conditions for inflammatory factor, µ, contractile agonist concentration, k, and volume fractions, Õa, a =
p, c, e, along with the initial geometry of the airway, are given in Table 1. Rate constants for the mass balance
equations and material parameters, consistent between the two layers, are given in Table 2. Model parameters
di ering between the layers are given in Table 3.
3 Sensitivity Study
We performed a one-at-a-time sensitivity study by varying parameters aµ, cdµ, ak, cdk, Tc, akµ, and ac (Fig. S1).
For each parameter, simulations were performed for a range of 100 values, with inflammatory challenges (except
for parameter ak, in which the airways were challenged with contractile agonists) at a frequency of one per day for
50 days, followed by a resolution period. Change in inner radius, from the initial value (R1=1.8mm), at 5 days post
final challenge was used to assess the results. The model is highly sensitive to aµ and cdµ, as increased remodelling
(represented by decreased inner radius) is associated with increasing magnitude (aµ), decreasing clearance (cdµ)
of inflammatory factor µ, with the former exhibiting a linear response above a certain threshold and the latter a
nonlinear response. Moreover, the model is highly sensitive to contractile agonist magnitude (ak) in the agonist-
challenge simulations. Note that the curve for ak in Fig. S1 does not pass through zero. The reason for this is that, at
the default value of ak and cdk (Table 2), the simulations with contractile agonist challenges at a frequency of 1 per
day over 50 days results in contraction into the lumen. A nonlinear decrease in radius is associated with decreasing
clearance of contractile agonist concentration, k, with a strong threshold e ect observed with decreasing cdk. The
model is less sensitive to this parameter than magnitude, clearance of µ (subject to inflammatory challenges).
1 Remark: Initially, ∆r = 0.002mm in the inner layer and 0.005mm in the outer layer. For all times, ∆r < 0.2mm, even in the
extreme (unrealised) case in which only the airway inner layer grows into the lumen.
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Table 2: Default Model Parameters Consistent Between the Two Layers
Parameter Definition Value Units
Constants
ﬂTc Contractile ASMC density 1.050 mg mm≠3
ﬂTp Proliferative ASMC density 1.050 mg mm≠3
ﬂTe Extracellular matrix density 1.050 mg mm≠3
ﬂTf Fluid mass density 1.000 mg mm≠3
Õw Fluid volume fraction 0.70
Inflammation and Agonist Rate Constants
aµ Stimulus amplitude for inflammatory factor, µ 3 mg mm≠3 day≠1
cdµ Decay rate of inflammatory factor, µ 5 day≠1
µ1 First inflammatory threshold 1 mg mm≠3
µ2 Second inflammatory threshold 2.5 mg mm≠3
ak Stimulus amplitude for contractile agonist, k 4.64x10≠2 mg mm≠3 day≠1
cdk Decay rate of contractile agonist, k 2 day≠1
akµ Inflammation-induced agonist release coe cient 0.001 day≠1
ac Contraction-induced agonist release coe cient 0.001 mg mm≠3 cmH2O≠1 day≠1
Event Parameters
d Duration of inflammation/agonist administration 1/3
‡ Event parameter 0.01
Ê Inflammation, µ, or contractile agonist, k, 1 day≠1
challenge frequency
T Time scale 1000 days
Mechanical/Material Parameters
÷p Proliferative ASMC passive isotropic sti ness 51.84 cmH2O
÷c Contractile ASMC passive isotropic sti ness 51.84 cmH2O
Cc Contractile ASMC passive anisotropic sti ness 1.14x10≠3 cmH2O
—c Contractile ASMC passive anisotropic 2.74
exponential parameter
÷e ECM passive isotropic sti ness 51.84 cmH2O
Ce ECM passive anisotropic sti ness 18.1 cmH2O
—e ECM passive anisotropic exponential parameter 1.48
Tc Agonist-induced active contraction parameter 1000 cmH2O
⁄act Collagen recruitment stretch 1
⁄z Axial stretch ratio 1
« Fiber angle 0 radians
P1 Lumen pressure 0 cmH2O
P2 External pressure 0 cmH2O
Also, the model is not very sensitive to changes in ASMC responsiveness to contractile agonist (Tc), inflammation-
induced contractile agonist release (akµ), and mechanical-stress induced contractile agonist release (ac), as each of
these result in only small (nonlinear) changes in inner radius.
4 Volume Fractions
In order to compare results more directly from the simulations in Figs. 4 and 6, we plot the volume fractions of the
airway wall constituents (proliferating, contractile ASMCs and ECM) as functions of the radius in Fig. S2. The
left column depicts the constituent volume fractions taken at 3 separate days (increasing in time, moving down the
column) from the simulation using the parameters corresponding to the circled point on the surfaces of Fig. 4a,b,
while the right column depicts those corresponding to the circled point on the surfaces of Fig. 6a,b. The volume
fractions of the constituents remain flat and only slightly increase during inflammation challenges (moving down
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Table 3: Default Model Parameters Di ering Between the Two Layers
Parameter Definition Inner Outer Units
layer layer
cp0 Baseline cell proliferation rate constant 0 1/3 day≠1
cpc Proliferative to contractile ASMC 0 2/3 day≠1
switching rate constant
cc0 Basline (low) contractile to proliferative 0 2.50x10≠3 day≠1
switching rate constant
cc1 Medium contractile to proliferative 0 5.0x10≠3 day≠1
switching rate constant
cc2 High contractile to proliferative 0 5.0x10≠2 day≠1
switching rate constant
ca Contractile cell apoptosis rate constant 0 1.19x10≠2 day≠1
cde Baseline ECM degradation rate constant 0 9.70x10≠3 day≠1
ce0 Baseline (low) ECM deposition rate constant 0 1.0x10≠3 mg mm≠3 day≠1
ce1 Medium ECM deposition rate constant 0 1.0x10≠3 mg mm≠3 day≠1
ce2 High ECM deposition rate constant 0 1.0x10≠3 mg mm≠3 day≠1
cpe ECM deposition, via proliferative cells, 0 1.0x10≠3 day≠1
rate constant
cfp Stress-induced cell proliferation rate 0 0 day≠1
constant
cfcp Stress-induced contractile to proliferative 0 5.0x10≠3 day≠1
ASMC switching rate constant
Fig. S1: Sensitivity Study. Change in inner radius, at 5 days post final challenge, from original radius R1=1.8mm, as a function of
change in parameter from default value (Table 2). The airway was challenged every day for a 50 day period with inflammation challenges,
except for the study varying ak, in which contractile agonist challenges were used. The default value for ak was chosen so that low
frequency challenges led to non-trivial remodelling, but at higher frequencies used here (one per day for 50 days), growth/contraction
into the lumen results with this default value.
the left column). The increase in proliferating ASMCs towards the outer wall of the airway is due to the tensile
mechanical stress-induced increase in phenotype switching rate. Thus, the figures in the right column depict the
local increase in proliferative, and associated decrease in contractile, ASMCs during phenotype switching. Also,
the airway geometry shifts to the right from day 28 to day 32, as the contractile agonist gradually clears from the
tissue and the airway relaxes.
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(a) (b)
(c) (d)
(e) (f)
Fig. S2: Volume Fractions vs. Radius. Volume fractions of proliferating, contractile airway smooth muscle cells (ASMCs) and extra-
cellular matrix (ECM) plotted as a function of radius taken at days 28, 30, and 32, corresponding to (left column) the circled point
on the surfaces of Fig. 4a,b and (right column) the circled point on the surfaces of Fig. 6a,b. The inner radius shifts to the left more
dramatically moving down the right column compared with the left column, as contractile agonist is cleared from the tissue following
the challenge. Clearly, contractile agonist-induced deformation is dominant in the agonist-challenge simulations.
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Fig. S3: Volume Fractions, Contractile Agonist Concentration, and Mechanical Stresses during Inflammatory Challenges. Illustrative
results are evaluated at the circled point on the surface of Fig. 4a: volume fractions of (a) contractile ASMCs, (b) extracellular matrix,
and concentration of (c) contractile agonist; Cauchy stresses in the (d) radial, (e) circumferential, and (f), (f) axial directions
5 Volume Fractions, Contractile Agonist Concentration, and Mechanical Stresses
The volume fractions, local contractile agonist concentrations, and mechanical stress distributions for the selected
points (not already included) in Figs. 4 and 6 are depicted in Figs. S3 and S4, respectively. During inflammation-
only challenges, the gradients of the constituents and agonists across the airway radius (Figs. S3a-c and 4c) are low
compared to contractile agonist challenges (Figs. S4a-c and 6c), in which the local mechanotransduction-induced
ASMC phenotype switching leads to local increases in ASM towards the outer wall (associated with regions on
increased circumferential tensile stress), and thus relatively higher volume fractions of proliferating ASMCs and
lower volume fractions of contractile ASMCs and ECM. For both inflammation (Fig. S3d-f) and agonist (Fig. S4d-
f) challenges, radial stresses are compressive in the mid-wall and zero at the boundaries (thus matching the zero
pressure boundary conditions), circumferential stresses are tensile in the outer potion of the wall and compressive
in the inner portion, and axial stresses are compressive (due to incompressibility), with agonist challenges resulting
in much higher stress magnitudes due to the active contraction.
6 E ect on Remodelling of Changes in Phenotype Switching Rate or Intrinsic Proliferation Rate
Modulated by Mechanical Tensile or Compressive Stresses
Similar amounts of remodelling are observed for increases in both tensile and compressive stress-modulated phe-
notype switching rates, cfcp and decreasing agonist clearance rate, cdk, with no clear threshold e ect (Fig. S5a,b).
For the same parameter ranges, agonist resolution times are also observed to be similar (note some simulation
results are not plotted due to contraction/growth into the lumen during challenges). Moreover, agonist resolution
time appears to be relatively independent of cfcp for both cases (Fig. S5c,d). For a selected parameter set (shown
as circles on the surfaces in Figs. S5a–d), distributions of the proliferative ASMC volume fraction are significantly
di erent in the two cases. Larger volume fractions are observed at the outer edge of the airway wall in the tensile
stress-modulated case (Fig. S5e) and at the inner edge in the compressive stress-modulated case (Fig. S5f).
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(a) (b) (c)
(d) (e) (f)
Fig. S4: Volume Fractions, Contractile Agonist Concentration, and Mechanical Stresses during Contractile Agonist Challenges.
Illustrative results are evaluated at the circled point on the surface of Fig. 6a: volume fractions of (a) contractile, (b) proliferating
ASMCs, and (c) extracellular matrix; Cauchy stresses in the (d) radial, (e) circumferential, and (f) axial directions
For our given initial conditions, both tensile and compressive stress-induced phenotype switching (cfcp) results
in a greater amount of airway remodelling (Fig. S5a,b) than stress-induced increase in proliferation rate (cfp ;
Fig. S6a,b); again, note that some simulation results are not plotted due to contraction/growth into the lumen
during challenges. Agonist retention is similar between the two cases (cf. Figs. S5c,d, S6c,d). Slightly less contraction
is observed during challenges with increasing cfcp compared with increasing cfp . In the former case (Fig. S5e, S5f),
contractile cells are lost due to phenotype switching, and in the latter case (Fig. S6e, S6f), the intrinsic proliferation
rate of the current (lower) population of proliferating ASMCs is increased.
7 Comparison to Previous Modelling Results
Qualitatively, very similar results were obtained between the current study and our previous study (Chernyavsky
et al (2014); Fig. S7). Severe remodelling in the former (red colour in Figs. S7a,b) corresponds to increased
remodelling towards the lumen in the latter (red colour in Figs. S7c,d, respectively corresponding to the inward
remodelling shown in Figs. 8a, 4a).
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Fig. S5: E ect of phenotype switching rate modulated by tensile vs compressive stress: Variation in (a), (b) remodelled geometry (1st
row) and (c), (d) agonist resolution rate (2nd row) with selected parameter values of stress-induced phenotype switching (cfcp) and
agonist resolution rate (cdk). The proliferating airway smooth muscle cell volume fraction (e), (f) is plotted as functions of radius and
time for parameter value pairs indicated by the circled points on the surfaces.
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Proliferation Rate Increase Proliferation Rate Increase
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Fig. S6: E ect of proliferation rate modulated by tensile vs compressive stress: Variation in (a), (b) remodelled geometry (1st row)
and (c), (d) agonist resolution rate (2nd row) with selected parameter values of stress-induced proliferation rate increase (cfp) and
agonist resolution rate (cdk). The proliferating airway smooth muscle cell volume fraction (e), (f) is plotted as functions of radius and
time for parameter value pairs indicated by the circled points on the surfaces.
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(a) (b)
(c) (d)
Fig. S7: Comparison of Current Model Results to Chernyavsky et al (2014). Top row: results from Chernyavsky et al (2014), showing
fold-increase in ASM population size after 300 days (colour scale) as a function of the inflammation resolution rate and the (a)
inflammation magnitude or (b) inflammation challenge frequency; Bottom row: results from current study, showing inner radius at
5 days post final inflammatory challenge (colour scale) as a function of the inflammation resolution rate and the (c) inflammation
magnitude (rotated view of Fig. 8a) or (d) challenge frequency (rotated and zoomed view of Fig. 4a).
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